Search results
Results from the WOW.Com Content Network
[10] [11] On 4 September 2015, the NHS announced it would no longer pay for 17 different cancer medications. The Telegraph reported that over 5,000 patients with breast, bowel, skin, and pancreatic cancers would be affected. [12] A five-year Cancer Strategy Implementation Plan was published by NHS England in 2015.
Lorenzo was deployed across more than 20 NHS trusts across the United Kingdom between 2010 and 2015, with most trusts progressing procurement activities to replace the system as of 2020. Lorenzo has been a highly criticised platform, with NHS reviews and coroner investigations finding the system responsible for a number of adverse patient events.
In November 2013 NHS England launched a clinical digital maturity index to measure the digital maturity of NHS providers [4] but 40% of NHS managers surveyed by the Health Service Journal did not know their ranking, and the same proportion said improving their ranking was of low or very low priority. [5] in 2022 the 211 trusts progress was ...
An early warning system (EWS), sometimes called a between-the-flags or track-and-trigger chart, is a clinical tool used in healthcare to anticipate patient deterioration by measuring the cumulative variation in observations, most often being patient vital signs and level of consciousness. [1]
It adopted the responsibility of delivering the NHS National Programme for IT (NPfIT), an initiative by the Department of Health to move the National Health Service (NHS) in England towards a single, centrally-mandated electronic care record for patients and to connect 30,000 general practitioners to 300 hospitals, providing secure and audited ...
This is a list of countries by cancer frequency, as measured by the number of new cancer cases per 100,000 population among countries, based on the 2018 GLOBOCAN statistics and including all cancer types (some earlier statistics excluded non-melanoma skin cancer).
The NHS measures medical need in terms of quality-adjusted life years (QALYs), a method of quantifying the benefit of medical intervention. [7] It is argued that this method of allocating healthcare means some patients must lose out in order for others to gain, and that QALY is a crude method of making life and death decisions. [8]
This distinction must be made by both the treating physicians and the cancer patients themselves. Many oncologists in their daily clinical practice follow their patients' malignant disease by means of repeated imaging studies and make decisions about continuing therapy on the basis of both objective and symptomatic criteria.